Is obesity considered for thromboprophylaxis prescription? A post-hoc analysis of the SiFMI 2017 study

Is obesity considered for thromboprophylaxis prescription? A post-hoc analysis of the SiFMI 2017 study

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thrombosis research 2022-10, Vol.218, p.138-141
Hauptverfasser: Giraud, Valentin, Cohen-Aubart, Fleur, Puyade, Mathieu, Bourgarit, Anne, Martin, Mickaël
Format: Artikel
Sprache:eng
Schlagworte:
Obesity
Primary prevention
Prophylaxis
Venous thrombosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 141
container_issue
container_start_page 138
container_title Thrombosis research
container_volume 218
creator Giraud, Valentin
Cohen-Aubart, Fleur
Puyade, Mathieu
Bourgarit, Anne
Martin, Mickaël
description
doi_str_mv 10.1016/j.thromres.2022.08.013
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2708258799</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S004938482200353X</els_id><sourcerecordid>2708258799</sourcerecordid><originalsourceid>FETCH-LOGICAL-c222t-4e0a5b120115bb437527641068514d16b1082f02d46a9a0824eab2aa7ad62da03</originalsourceid><addsrcrecordid>eNqFkD1PwzAQhi0EEqXwF5BHlgTbdb4mqCoKlYoYgNly7IvqKo2DL0Xk3-NSmJnOw_u8d34IueYs5Yznt9t02AS_C4CpYEKkrEwZn52QCS-LKhGyEKdkwpisklkpy3NygbhljBe8yiakWSH1NaAbRmp8h85CAEsbH-hPa-374PvN2Oovh7SPS0xw_eB8d0fntPc4JBtvqO50O2JM-CZyQF_d8nlFRdxCcdjb8ZKcNbpFuPqdU_K-fHhbPCXrl8fVYr5OjBBiSCQwndU8cjyrazkrMlHkkrO8zLi0PK85K0XDhJW5rnR8S9C10LrQNhdWs9mU3Bx749Ufe8BB7RwaaFvdgd-jEkWEsuilitH8GDXBIwZoVB_cTodRcaYOYtVW_YlVB7GKlSqKjeD9EYT4kU8HQaFx0BmwLoAZlPXuv4pv74uFLQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2708258799</pqid></control><display><type>article</type><title>Is obesity considered for thromboprophylaxis prescription? A post-hoc analysis of the SiFMI 2017 study</title><source>Elsevier ScienceDirect Journals</source><creator>Giraud, Valentin ; Cohen-Aubart, Fleur ; Puyade, Mathieu ; Bourgarit, Anne ; Martin, Mickaël</creator><creatorcontrib>Giraud, Valentin ; Cohen-Aubart, Fleur ; Puyade, Mathieu ; Bourgarit, Anne ; Martin, Mickaël ; 2017 SiFMI study group</creatorcontrib><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/j.thromres.2022.08.013</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><subject>Obesity ; Primary prevention ; Prophylaxis ; Venous thrombosis</subject><ispartof>Thrombosis research, 2022-10, Vol.218, p.138-141</ispartof><rights>2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c222t-4e0a5b120115bb437527641068514d16b1082f02d46a9a0824eab2aa7ad62da03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Giraud, Valentin</creatorcontrib><creatorcontrib>Cohen-Aubart, Fleur</creatorcontrib><creatorcontrib>Puyade, Mathieu</creatorcontrib><creatorcontrib>Bourgarit, Anne</creatorcontrib><creatorcontrib>Martin, Mickaël</creatorcontrib><creatorcontrib>2017 SiFMI study group</creatorcontrib><title>Is obesity considered for thromboprophylaxis prescription? A post-hoc analysis of the SiFMI 2017 study</title><title>Thrombosis research</title><subject>Obesity</subject><subject>Primary prevention</subject><subject>Prophylaxis</subject><subject>Venous thrombosis</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkD1PwzAQhi0EEqXwF5BHlgTbdb4mqCoKlYoYgNly7IvqKo2DL0Xk3-NSmJnOw_u8d34IueYs5Yznt9t02AS_C4CpYEKkrEwZn52QCS-LKhGyEKdkwpisklkpy3NygbhljBe8yiakWSH1NaAbRmp8h85CAEsbH-hPa-374PvN2Oovh7SPS0xw_eB8d0fntPc4JBtvqO50O2JM-CZyQF_d8nlFRdxCcdjb8ZKcNbpFuPqdU_K-fHhbPCXrl8fVYr5OjBBiSCQwndU8cjyrazkrMlHkkrO8zLi0PK85K0XDhJW5rnR8S9C10LrQNhdWs9mU3Bx749Ufe8BB7RwaaFvdgd-jEkWEsuilitH8GDXBIwZoVB_cTodRcaYOYtVW_YlVB7GKlSqKjeD9EYT4kU8HQaFx0BmwLoAZlPXuv4pv74uFLQ</recordid><startdate>202210</startdate><enddate>202210</enddate><creator>Giraud, Valentin</creator><creator>Cohen-Aubart, Fleur</creator><creator>Puyade, Mathieu</creator><creator>Bourgarit, Anne</creator><creator>Martin, Mickaël</creator><general>Elsevier Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202210</creationdate><title>Is obesity considered for thromboprophylaxis prescription? A post-hoc analysis of the SiFMI 2017 study</title><author>Giraud, Valentin ; Cohen-Aubart, Fleur ; Puyade, Mathieu ; Bourgarit, Anne ; Martin, Mickaël</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c222t-4e0a5b120115bb437527641068514d16b1082f02d46a9a0824eab2aa7ad62da03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Obesity</topic><topic>Primary prevention</topic><topic>Prophylaxis</topic><topic>Venous thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Giraud, Valentin</creatorcontrib><creatorcontrib>Cohen-Aubart, Fleur</creatorcontrib><creatorcontrib>Puyade, Mathieu</creatorcontrib><creatorcontrib>Bourgarit, Anne</creatorcontrib><creatorcontrib>Martin, Mickaël</creatorcontrib><creatorcontrib>2017 SiFMI study group</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Giraud, Valentin</au><au>Cohen-Aubart, Fleur</au><au>Puyade, Mathieu</au><au>Bourgarit, Anne</au><au>Martin, Mickaël</au><aucorp>2017 SiFMI study group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is obesity considered for thromboprophylaxis prescription? A post-hoc analysis of the SiFMI 2017 study</atitle><jtitle>Thrombosis research</jtitle><date>2022-10</date><risdate>2022</risdate><volume>218</volume><spage>138</spage><epage>141</epage><pages>138-141</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><pub>Elsevier Ltd</pub><doi>10.1016/j.thromres.2022.08.013</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0049-3848
ispartof Thrombosis research, 2022-10, Vol.218, p.138-141
issn 0049-3848
1879-2472
language eng
recordid cdi_proquest_miscellaneous_2708258799
source Elsevier ScienceDirect Journals
subjects Obesity
Primary prevention
Prophylaxis
Venous thrombosis
title Is obesity considered for thromboprophylaxis prescription? A post-hoc analysis of the SiFMI 2017 study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T13%3A24%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20obesity%20considered%20for%20thromboprophylaxis%20prescription?%20A%20post-hoc%20analysis%20of%20the%20SiFMI%202017%20study&rft.jtitle=Thrombosis%20research&rft.au=Giraud,%20Valentin&rft.aucorp=2017%20SiFMI%20study%20group&rft.date=2022-10&rft.volume=218&rft.spage=138&rft.epage=141&rft.pages=138-141&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/j.thromres.2022.08.013&rft_dat=%3Cproquest_cross%3E2708258799%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2708258799&rft_id=info:pmid/&rft_els_id=S004938482200353X&rfr_iscdi=true